Tag Archives: FDA approval

This article continues on from FDA Restrictions on US Stem Cell Research. Here are the reasons the FDA views adipose SVF stem cells as a drug that requires clinical trials: -The structural fat tissue is processed into another substance (in … Continue reading →

A new letter has been released by the FDA Tissue Reference Group (TRG). The TRG decides on policy interpretations of the FDA’s regulations. The letter in question states that adipose SVF for orthopedic indications is considered to be a new … Continue reading →